NCT00879645View on ClinicalTrials.gov

Pharmacokinetic Assessment of Sodium Sulfide in Subjects With Impaired Renal Function

PHASE1TerminatedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Renal Impairment
Interventions
DRUG

Sodium Sulfide

Sodium sulfide administered intravenously at 1.5 mg/kg/hr for 3 hours

DRUG

Sodium Sulfide

Sodium sulfide intravenously at 1.5 mg/kg/hr for 3 hours

DRUG

Sodium Sulfide

Sodium sulfide intravenously at 1.5 mg/kg/hr for 3 hours

DRUG

Sodium Sulfide

Sodium sulfide intravenously at 1.0 mg/kg/hr for 3 hours

Trial Locations (1)

55404

DaVita Clinical Research, Minneapolis

Sponsors

Lead Sponsor

Mallinckrodt
All Listed Sponsors
lead

Mallinckrodt

INDUSTRY